Abstract: Technology for operating a computer system to manage network communications with plural devices, comprising retrieving from a registry one or more device capability profiles for the identified devices, the registry linking a device capability profile with each of the identified plural devices and the device capability profile identifying one or more capabilities of a device; operating in the computer system a message translation manager to adapt a message according to a linked device capability profile of each of the plural devices; and sending the message in adapted form to each identified one of the plural devices.

Abstract: The present invention primarily relates to a process for producing certain substituted 2-allylanilines of the hereinbelow-defined formula (I) and their use in a process for producing substituted 4-aminoindane derivatives of the hereinbelow-defined formula (V). The present invention further relates to a process for producing fungicidal indanyl carboxamides. In particular, the present invention relates to a process for producing 2-(difluoromethyl)-N-(1,1-dimethyl-3-propyl-2,3-dihydro-1H-inden-4-yl)nicotinamide and/or 3-(difluoromethyl)-N-[(R)-2,3-dihydro-1,1,3-trimethyl-1H-inden-4-yl]-1-methylpyrazole-4-carboxamide.

Abstract: The present invention relates to a process for preparing compounds of the formula (I) starting from compounds of the formula (II) in which R1, R2 and R3 have the abovementioned meaning and where R1 and R3 are not simultaneously hydrogen in any compound. The invention further provides the compounds of the formulae (IVa), (IVb), (V) and (VI) in which R1, R2, R3, R5, M and n have the abovementioned meaning.

Abstract: The present invention relates to a process for preparing compounds of the formula (I) starting from compounds of the formula (II) wherein X, R1, R2, R3, R4, U, A1, A2, A3 and A4 are defined as described above. The invention relates to compounds of the formulae (III) and (IV) wherein all variables are defined as above.

Abstract: The present invention relates to compounds of formula I as defined herein, and salts and solvates thereof, that function as inhibitors of cell division cycle 7 (Cdc7) kinase enzyme activity. The present invention also relates to pharmaceutical compositions comprising them, and to their use in the treatment of proliferative disorders, such as cancer, as well as other diseases or conditions in which Cdc7 kinase activity is implicated.

Abstract: Trace data is received for a first execution of a first query on first tables having first data values. Second data values are generated for second tables from the trace data and without accessing the first data values. The second data values are configured to reproduce, by a second execution of a second query, the evaluation states from the first execution. Evaluation states from the first execution are reproduced without accessing the first data values by performing the second execution of the second query on the second data values. The first execution evaluates only a first subset of the first data values and the generating the second data values from the trace data generates second data values corresponding to the first subset. The second execution only evaluates ones of the second data values that correspond to data values of the first subset.

Abstract: A computer-implemented method of operation of a translation manager intermediating message distribution in a plurality of networked devices, comprising receiving at the translation manager a request from a networked device for registration; parsing the message by the translation manager to derive an identifier of the networked device; determining by the translation manager at least one capability of the networked device; creating a pairing of the identifier of the networked device and a profile comprising the at least one capability of the networked device; storing the pairing in a data store for use by the translation manager on request to translate a message. The storing the pairing may comprise populating a lookup table and/or operating a database.

Abstract: The present invention relates to disubstituted 3-pyrazole carboxylates of the formula (I) and a process for their preparation wherein R1, R2, R3, R4 and n are defined as above.

Abstract: Trace data is received that was captured for an execution of a query on first tables when execution trouble occurs during an execution of the query on the first tables. Trace data includes counts of evaluation states caused by the execution and includes identifications of portions of the query that reference variables of the first tables and that correspond with the evaluation states. Second tables are generated from the evaluation state counts and the identifications of the trace data without accessing data values of the first tables, so that the first tables are kept private. Evaluation states are reproduced from the execution of the query on the first tables by executing the query on the second tables without accessing the data values of the first tables.

Abstract: The present invention relates primarily to a process for preparing certain phosphorus-containing cyanohydrins of the formula (I), and also to certain phosphorus-containing cyanohydrins per se and to their use for the preparation of glufosinate and/or glufosinate salts. The present invention further relates to certain mixtures particularly suitable for preparing the phosphorus-containing cyanohydrins of the formula (I).

Abstract: The present invention primarily relates to a process for producing certain phosphorus-containing cyanohydrin esters of formula (I) and the use thereof for producing glufosinate/glufosinate salts. The present invention further relates to a process for producing glufosinate/glufosinate salts.

Abstract: The invention relates to a method for preparing methyl 4-[(4,5-dihydro-3-methoxy-4-methyl-5-oxo-1H-1,2,4-triazol-1-yl)carbonyl)sulfamoyl]-5-methylthiophene-3-carboxylate from 4-methoxycarbonyl-2-methylthiophene-3-sulfonyl chloride in the presence of an imidazole base substituted in the 1-position or in the presence of a mixture of bases comprising an imidazole base substituted in the 1-position (N-alkylimidazole).

Abstract: The present invention relates primarily to processes for preparing particular phosphorus-containing ?-aminonitriles of the formulae (Ia) and (Ib) defined hereinafter from corresponding phosphorus-containing cyanohydrin esters and to the use thereof for preparation of glufosinate or of glufosinate salts. The present invention further relates to a process for preparing glufosinate or glufosinate salts.

Abstract: The present invention relates to a method for preparing substituted 2,3-dihydro-l-benzofuran derivatives.

Abstract: The present invention relates to a method for preparing substituted 2,3-dihydro-1-benzofuran derivatives.

Abstract: The present invention relates primarily to processes for preparing particular phosphorus-containing ?-aminonitriles of the formulae (Ia) and (Ib) defined hereinafter from corresponding phosphorus-containing cyanohydrin esters and to the use thereof for preparation of glufosinate or of glufosinate salts. The present invention further relates to a process for preparing glufosinate or glufosinate salts.

Abstract: The present invention relates to a method for preparing 3-substituted 2-vinylphenyl sulfonates.

Abstract: The present invention relates to a new process for preparing 3-chloro-2-vinylphenylsulfonate derivatives.

Abstract: The present invention primarily relates to a process for producing certain phosphorus-containing cyanohydrin esters of formula (I) and the use thereof for producing glufosinate/glufosinate salts. The present invention further relates to a process for producing glufosinate/glufosinate salts.

Abstract: A series of pyrazolo[3,4-d]pyrimidine derivatives that are substituted at the 4-position by a diaza monocyclic, bridged bicyclic or spirocyclic moiety, are beneficial in the treatment and/or prevention of various human ailments, including inflammatory, autoimmune and oncological disorders; viral diseases and malaria; and organ and cell transplant rejection.